At GeneOmbio Technologies, we understand the critical importance of identifying drug resistance in tuberculosis, to ensure effective patient treatment. Our comprehensive molecular testing services include advanced diagnostics for TB drug resistance, specifically targeting Multidrug Resistant (MDR) and Extensively Drug-Resistant (XDR) strains.  Available technology rapidly detects genetic mutations associated with resistances, we empower clinicians to make timely decisions and minimize treatment failures, preventing the spread of these challenging infections. This crucial insight supports optimal patient management and contributes significantly to global efforts in combating antimicrobial resistance.